MedTrace Logo

Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study

NCT06747039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2024-12-24

No results posted yet for this study

Summary

The aim of this observational study is to evaluate the effects of cannabis extract Avextra 10/10 solution on pain, fatigue, sleep, and quality of life among patients affected by fibromyalgia (FM) syndrome. The main question it aims to answer is:

Does cannabis extract have a positive effect on pain after 12 weeks in these patients?

Participants diagnosed from FM will be evaluated and will fill survey about their pain, fatigue, sleep, anxiety, depression and quality of life at baseline, 4 weeks, 8 weeks and 12 weeks after the initiation of cannabis extract Avextra 10/10 solution.

Conditions

  • Fibromyalgia (FM)

Sponsors & Collaborators

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    lead OTHER

Principal Investigators

  • Piercarlo Sarzi Puttini, Medical Doctor · IRCCS Ospedale Galeazzi Sant'Ambrogio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-05
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06747039 on ClinicalTrials.gov